Metropolitan Life Insurance Company (MetLife)’s Kronos Bio KRON Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,029	Closed	-$10.1K	–	2361
2022 Q3	$10.1K	Buy	+3,029	New	+$13.7K	﹤0.01%	2283
2022 Q2	–	Sell	-2,796	Closed	-$20.2K	–	2404
2022 Q1	$20.2K	Sell	2,796 -9,055	-76%	-$77.2K	﹤0.01%	2092
2021 Q4	$161K	Hold	11,851	–	–	﹤0.01%	2170
2021 Q3	$248K	Hold	11,851	–	–	﹤0.01%	1914
2021 Q2	$284K	Buy	11,851 +7,552	+176%	+$191K	﹤0.01%	1900
2021 Q1	$126K	Sell	4,299 -520	-11%	-$15.2K	﹤0.01%	2321
2020 Q4	$144K	Buy	+4,819	New	+$151K	﹤0.01%	2157

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s KRON Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Kronos Bio (KRON) in Q4 2022, closing a stake of 3,029 shares — an estimated $10.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KRON in Q4 2020 and held it in 7 quarters. The position peaked at $284K in Q2 2021. 97 funds tracked by Wall St. Rank hold KRON as of Q4 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Kronos Bio position as of Q4 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,029 Kronos Bio shares in Q4 2022, an estimated $10.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Kronos Bio in Q4 2020 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s Kronos Bio position peaked at $284K in Q2 2021.
97 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.